BÁO CÁO Y HỌC: "RELAXIN''''S INDUCTION OF METALLOPROTEINASES IS ASSOCIATED WITH THE LOSS OF COLLAGEN AND GLYCOSAMINOGLYCANS IN SYNOVIAL JOINT" PPSX

References 1. Minella AC, Clurman BE. Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle. 2005;4(10):1356-9. 2. Fuchs SY. Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor. Cancer Biol Ther. 2005;4(5):506-8. 3. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed[r]

n 342 219 211 8 chd present 81 71 70 1 0.033 BMI (kg/m²) 22.1±1.5 22.9±1.3 22.9±1.1 23.1±1.1 0.023 Cholesterol (mg/dl) 270.5±51.2 266.2±89.4 266.4±93.2 262±64.5 ns LDL 183±46.8 189±54.8 194±53.9 174.6±62.5 ns HDL 65.5±20.6 53.5±16 54±16 58.2±17.8 0.004 VLDL 22±13.2 23±8.8 23.4±8.8 19.2±4.8 ns Trigly[r]

group relegated to the same caloric-restricted diet as the Test group. Many published studies concerning methods to combat obesity provide only scale weight loss as the principal end point. The assumption that scale weight loss is synonymous with fat loss, however, is not al-ways true [26,27]. Scale[r]

Sweden. Acta Paediatr Scand 1982;293:1-21. 4. Silver RI, Rodriguez R, Chang TS, Gearhart JP. In vitro fertilization is associated with an increased risk of hypospadias. J Urol 1999;161:1954-7. 5. Czeizel A. Increasing trends in congenital malformations of male external genitalia. Lancet 1985;1:462-3[r]

association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in patient s[r]

A group of 16 females, aged 80-93 years old, was divided into 2 groups according to their baseline DHEA-S lev-els: Lower Halves (N = 8) and Upper Halves (N = 8), and participated in a 4-month exercise intervention trial. Insulin response with an oral glucose tolerance test (OGTT), cholesterol[r]

atrophy with no interaction. Our data provided further evidence for host genetic factors in the susceptibility to H pylori infection and H. pylori-related gastric atrophy. Further investigation of the association requires much larger studies, as well as confirmatory biological studies with histologi[r]

association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in patient s[r]

acceptable participation rate as well as less selection bias. We have chosen to report from the youngest age cohort participating in “The Prospective Population Study of Women in Gothenburg” as this was the age group in which lung function status was most thoroughly examined and selection bias due t[r]

genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther. 2005; 22: 1033-40. 25. Sapone A, Vaira D, Trespidi S, et al. The clinical role of cytochrome P450 genotypes in Helicobacter pylori managem[r]

Trepo C, et al. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy. J Clin Virol 2005;33:150-157. 49. Villa E, Grottola A, Buttafoco P, Colantoni A, Bagni A, Ferretti I, Cremonini C, et al. High doses of alpha-interferon are required in chronic hepatitis du[r]

treatment, but relapse occurs frequently once treatment is discontinued.[70] Other frequent extrahepatic manifestations found in patient with chronic HCV infection are membranoproliferative glomerulonephritis, porphyria cutaneous tarda, lichen planus, and vitiligo. There is also some data that sugge[r]

Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62 3. Perez CM, Suarez E, Torres EA, Roman K, Colon V. Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in S[r]

4. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Poupon RE, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-1440. 5. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Ki[r]

6. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65(4):1416–1421. 7. Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou I, Funa[r]

histopathological aspects. J Gastroenterology Hepatic, 1991. 6: 125-130. 5. Marshall BJ., Armstrong JA., and McGechie DB. Attempt to fulfill Koch’s postulate for pyloric Campylobacter. Med J Aust, 1985. 142: 436-439. 6. Sipponen P. Gastric cancer — a long-term consequence of Helicobacter pylo[r]

hepatitis C virus to CD81. Science 1998; 282: 938-41. 25. Agnello V, Abel G, Elfahal M, Knight GB and Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 1999; 96: 12766-71. 26. Scarselli E, Ansuini H, Cerino R,[r]

as assessed by an HCV RNA assay with a lower limit of detection of 50 IU/ml or less 24 weeks after the end of treatment [18]. Initiation of therapy Only patients with detectable HCV RNA should be considered for pegylated IFN alfa and ribavirin combination therapy [18]. The decision to treat patients[r]

randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140(5):346-55. 27. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992;15(4):567-71. 28. Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients wi[r]

Int. J. Med. Sci. 2006, 3 69International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):69-74 ©2006 Ivyspring International Publisher. All rights reserved Review Treatment of Chronic HCV Infection in Special Populations John Hoefs 1 and Vikramjit S. Aulakh 2 1. Division[r]